购物车
全部删除
您的购物车当前为空
别名 DG70
GSK1733953A 可作为一种小分子结核分枝杆菌呼吸抑制剂,对 MenG 活性有抑制作用,IC50 值为 2.6 ± 0.6 μM。GSK1733953A 是一种具有选择性的联苯苯甲酰胺,对结核分枝杆菌去甲基萘醌甲基转移酶的催化甲基化有抑制作用,对结核分枝杆菌H4Rv的MIC为8.37 μg/ml,对耐药菌株的MIC为1.2至9.6 μg/ml。GSK1733953A 是治疗结核病的候选化合物。

GSK1733953A 可作为一种小分子结核分枝杆菌呼吸抑制剂,对 MenG 活性有抑制作用,IC50 值为 2.6 ± 0.6 μM。GSK1733953A 是一种具有选择性的联苯苯甲酰胺,对结核分枝杆菌去甲基萘醌甲基转移酶的催化甲基化有抑制作用,对结核分枝杆菌H4Rv的MIC为8.37 μg/ml,对耐药菌株的MIC为1.2至9.6 μg/ml。GSK1733953A 是治疗结核病的候选化合物。
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 10 mg | ¥ 283 | 现货 | |
| 25 mg | ¥ 455 | 现货 | |
| 50 mg | ¥ 747 | 现货 |
GSK1733953A 相关产品
| 产品描述 | GSK1733953A can be used as a small molecule Mycobacterium tuberculosis respiration inhibitor with an inhibitory effect on MenG activity and an IC50 value of 2.6 ± 0.6 μM.GSK1733953A is a selective biphenylbenzamide with an inhibitory effect on the catalytic methylation of the Mycobacterium tuberculosis desmethylnaphthoquinone methyltransferase, and the MIC of GSK1733953A against Mycobacterium tuberculosis H4Rv was 8.37 μg/ml. MIC of 8.37 μg/ml and MIC of 1.2 to 9.6 μg/ml against drug-resistant strains.GSK1733953A is a candidate compound for the treatment of tuberculosis. |
| 靶点活性 | MenG:2.6 ± 0.6 μM |
| 别名 | DG70 |
| 分子量 | 385.82 |
| 分子式 | C21H17ClFNO3 |
| CAS No. | 930470-97-6 |
| Smiles | O(C)C1=C(C=C(NC(=O)C2=C(Cl)C=C(F)C=C2)C=C1)C3=CC=C(OC)C=C3 |
| 密度 | 1.295 g/cm3 (Predicted) |
| 存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||||||||||||
| 溶解度信息 | DMSO: 40 mg/mL (103.68 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
| 体内实验配方 | 10% DMSO+40% PEG300+5% Tween-80+45% Saline: 2 mg/mL (5.18 mM), Sonication is recommeded. 请按顺序添加溶剂,在添加下一种溶剂之前,尽可能使溶液澄清。如有必要,可通过加热、超声、涡旋处理进行溶解。工作液建议现配现用。以上配方仅供参考,体内配方并不是绝对的,请根据不同情况进行调整。 | |||||||||||||||||||||||||||||||||||
溶液配制表 | ||||||||||||||||||||||||||||||||||||
DMSO
| ||||||||||||||||||||||||||||||||||||
评论内容